BELO CORPO ESTÉTICA E BELEZA LTDA. – Trademark Portfolio

Entity Type: 16

BELO CORPO ESTÉTICA E BELEZA LTDA. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include FORMAH, FORMAH BODY SCULPTING, and FORMAH BRAZILIAN BEAUTY CENTER. The owner is based in São José dos Campos.

Av. Andrômeda, 3222

São José dos Campos 12233-001 , BR

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BELO CORPO ESTÉTICA E BELEZA LTDA.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does BELO CORPO ESTÉTICA E BELEZA LTDA. have?

BELO CORPO ESTÉTICA E BELEZA LTDA. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does BELO CORPO ESTÉTICA E BELEZA LTDA. file in?

BELO CORPO ESTÉTICA E BELEZA LTDA. files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are BELO CORPO ESTÉTICA E BELEZA LTDA.'s most well-known trademarks?

BELO CORPO ESTÉTICA E BELEZA LTDA.'s registered trademark portfolio includes well-known marks such as FORMAH, FORMAH BODY SCULPTING, and FORMAH BRAZILIAN BEAUTY CENTER. These are among 4 currently registered trademarks in the portfolio.

What is BELO CORPO ESTÉTICA E BELEZA LTDA.'s trademark registration success rate?

BELO CORPO ESTÉTICA E BELEZA LTDA. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.